Q2 2023 Holdings
Filed 2023-08-10 | 6 holdings | $231.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $124.8M | 3,946,630 | 53.8% |
| Design Therapeutics Inc(DSGN) | COM | 25056L103 | $41.1M | 6,526,476 | 17.7% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $30.6M | 1,794,600 | 13.2% |
| ARS Pharmaceuticals Inc(SPRY) | COM | 82835W108 | $26.9M | 4,012,903 | 11.6% |
| Effector Therapeutics Inc | COM | 28202V108 | $5.6M | 6,822,114 | 2.4% |
| Nkarta Inc(NKTX) | COM | 65487U108 | $2.9M | 1,333,333 | 1.3% |